Controlled comparative clinical trial of hearing benefit outcomes for users of the Cochlear™ Nucleus® 7 Sound Processor with mobile connectivity
Objectives: To assess subjective benefits and objective speech recognition performance following a take-home trial with the new Cochlear™ Nucleus ® 7 Sound Processor (SP), in experienced users of compatible cochlear implants from Cochlear Limited. Methods: A total of 37 adult participants were fitte...
Saved in:
| Published in | Cochlear implants international Vol. 20; no. 3; pp. 116 - 126 |
|---|---|
| Main Authors | , , |
| Format | Journal Article |
| Language | English |
| Published |
England
Taylor & Francis
04.05.2019
|
| Subjects | |
| Online Access | Get full text |
| ISSN | 1467-0100 1754-7628 1754-7628 |
| DOI | 10.1080/14670100.2019.1572984 |
Cover
| Abstract | Objectives: To assess subjective benefits and objective speech recognition performance following a take-home trial with the new Cochlear™ Nucleus
®
7 Sound Processor (SP), in experienced users of compatible cochlear implants from Cochlear Limited.
Methods: A total of 37 adult participants were fitted with the Nucleus 7 SP and used the device for up to one year. Baseline speech recognition was assessed at the initial fitting session, using each participant's own SP, and Client Oriented Scale of Improvement (COSI) goals were identified. Speech recognition was measured after 3 months of device use and outcomes of the COSI and a non-validated Processor Comparison Questionnaire (PCQ) were collected. After 11 months, a subset of subjects were tested on speech recognition delivered via direct wireless streaming from an Apple
®
smartphone to the SP and compatible hearing aid on the opposite side (if worn).
Results: The COSI and PCQ instruments both indicated significant improvement in perceived subjective benefits in comparison to the participants' previous SPs. Direct streaming via an Apple mobile phone showed improvements when compared with the acoustic alone condition. Standard speech recognition in quiet and noise was equivalent to that obtained using a previous generation SP which uses the same basic processing as the Nucleus 7 Sound Processor.
Conclusions: The incremental refinements provided by the Nucleus 7 Sound Processor provide real-world benefits in key areas such as upgraded wireless connectivity. The COSI proved to be an effective tool for individualized assessment of specific benefits that may not be addressed by more standardized instruments. |
|---|---|
| AbstractList | Objectives: To assess subjective benefits and objective speech recognition performance following a take-home trial with the new Cochlear™ Nucleus
®
7 Sound Processor (SP), in experienced users of compatible cochlear implants from Cochlear Limited.
Methods: A total of 37 adult participants were fitted with the Nucleus 7 SP and used the device for up to one year. Baseline speech recognition was assessed at the initial fitting session, using each participant's own SP, and Client Oriented Scale of Improvement (COSI) goals were identified. Speech recognition was measured after 3 months of device use and outcomes of the COSI and a non-validated Processor Comparison Questionnaire (PCQ) were collected. After 11 months, a subset of subjects were tested on speech recognition delivered via direct wireless streaming from an Apple
®
smartphone to the SP and compatible hearing aid on the opposite side (if worn).
Results: The COSI and PCQ instruments both indicated significant improvement in perceived subjective benefits in comparison to the participants' previous SPs. Direct streaming via an Apple mobile phone showed improvements when compared with the acoustic alone condition. Standard speech recognition in quiet and noise was equivalent to that obtained using a previous generation SP which uses the same basic processing as the Nucleus 7 Sound Processor.
Conclusions: The incremental refinements provided by the Nucleus 7 Sound Processor provide real-world benefits in key areas such as upgraded wireless connectivity. The COSI proved to be an effective tool for individualized assessment of specific benefits that may not be addressed by more standardized instruments. To assess subjective benefits and objective speech recognition performance following a take-home trial with the new Cochlear™ Nucleus 7 Sound Processor (SP), in experienced users of compatible cochlear implants from Cochlear Limited. A total of 37 adult participants were fitted with the Nucleus 7 SP and used the device for up to one year. Baseline speech recognition was assessed at the initial fitting session, using each participant's own SP, and Client Oriented Scale of Improvement (COSI) goals were identified. Speech recognition was measured after 3 months of device use and outcomes of the COSI and a non-validated Processor Comparison Questionnaire (PCQ) were collected. After 11 months, a subset of subjects were tested on speech recognition delivered via direct wireless streaming from an Apple smartphone to the SP and compatible hearing aid on the opposite side (if worn). The COSI and PCQ instruments both indicated significant improvement in perceived subjective benefits in comparison to the participants' previous SPs. Direct streaming via an Apple mobile phone showed improvements when compared with the acoustic alone condition. Standard speech recognition in quiet and noise was equivalent to that obtained using a previous generation SP which uses the same basic processing as the Nucleus 7 Sound Processor. The incremental refinements provided by the Nucleus 7 Sound Processor provide real-world benefits in key areas such as upgraded wireless connectivity. The COSI proved to be an effective tool for individualized assessment of specific benefits that may not be addressed by more standardized instruments. To assess subjective benefits and objective speech recognition performance following a take-home trial with the new Cochlear™ Nucleus® 7 Sound Processor (SP), in experienced users of compatible cochlear implants from Cochlear Limited.OBJECTIVESTo assess subjective benefits and objective speech recognition performance following a take-home trial with the new Cochlear™ Nucleus® 7 Sound Processor (SP), in experienced users of compatible cochlear implants from Cochlear Limited.A total of 37 adult participants were fitted with the Nucleus 7 SP and used the device for up to one year. Baseline speech recognition was assessed at the initial fitting session, using each participant's own SP, and Client Oriented Scale of Improvement (COSI) goals were identified. Speech recognition was measured after 3 months of device use and outcomes of the COSI and a non-validated Processor Comparison Questionnaire (PCQ) were collected. After 11 months, a subset of subjects were tested on speech recognition delivered via direct wireless streaming from an Apple® smartphone to the SP and compatible hearing aid on the opposite side (if worn).METHODSA total of 37 adult participants were fitted with the Nucleus 7 SP and used the device for up to one year. Baseline speech recognition was assessed at the initial fitting session, using each participant's own SP, and Client Oriented Scale of Improvement (COSI) goals were identified. Speech recognition was measured after 3 months of device use and outcomes of the COSI and a non-validated Processor Comparison Questionnaire (PCQ) were collected. After 11 months, a subset of subjects were tested on speech recognition delivered via direct wireless streaming from an Apple® smartphone to the SP and compatible hearing aid on the opposite side (if worn).The COSI and PCQ instruments both indicated significant improvement in perceived subjective benefits in comparison to the participants' previous SPs. Direct streaming via an Apple mobile phone showed improvements when compared with the acoustic alone condition. Standard speech recognition in quiet and noise was equivalent to that obtained using a previous generation SP which uses the same basic processing as the Nucleus 7 Sound Processor.RESULTSThe COSI and PCQ instruments both indicated significant improvement in perceived subjective benefits in comparison to the participants' previous SPs. Direct streaming via an Apple mobile phone showed improvements when compared with the acoustic alone condition. Standard speech recognition in quiet and noise was equivalent to that obtained using a previous generation SP which uses the same basic processing as the Nucleus 7 Sound Processor.The incremental refinements provided by the Nucleus 7 Sound Processor provide real-world benefits in key areas such as upgraded wireless connectivity. The COSI proved to be an effective tool for individualized assessment of specific benefits that may not be addressed by more standardized instruments.CONCLUSIONSThe incremental refinements provided by the Nucleus 7 Sound Processor provide real-world benefits in key areas such as upgraded wireless connectivity. The COSI proved to be an effective tool for individualized assessment of specific benefits that may not be addressed by more standardized instruments. |
| Author | Warren, Chris D. Nel, Esti Boyd, Paul J. |
| Author_xml | – sequence: 1 givenname: Chris D. surname: Warren fullname: Warren, Chris D. email: cwarren@cochlear.com organization: Cochlear Ltd – sequence: 2 givenname: Esti surname: Nel fullname: Nel, Esti organization: Cochlear Ltd – sequence: 3 givenname: Paul J. surname: Boyd fullname: Boyd, Paul J. organization: Cochlear Ltd |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/30714500$$D View this record in MEDLINE/PubMed |
| BookMark | eNqFkUuOVCEUhonpjv3QJWgYOrklXLivONFUfCUd20QdEy4cLAwXSuB2p-buwB24gF6ES3ElclNVEwf2BM7g-85J_v8CnfjgAaEnlKwo6clzytuOUEJWNaHDijZdPfT8ATqnXcOrrq37kzIXplqgM3SR0jdCGOUNf4jOGOnKRMg5-rkOPsfgHGiswrSVUWZ7A1g5662SDudoyxsM3oCM1n_FI3gwNuMw5yJAwiZEPCeIaaHyBvA6qI0r9J8fv_CHWTmY0-873OFPYfYaf4xBQUpFurV5g6cwWlfuBe9BldM27x6hUyNdgseH_xJ9efP68_pddXX99v361VWlWNvmSnINzBhuaNNyRcemHXRr9Nhr3dKBj1JKxihpelC6lazmPe3HQRVAatYwxS7Rs_3ebQzfZ0hZTDYpcE56CHMSNe2GEtLAWUGfHtB5nECLbbSTjDtxDLIAL_aAiiGlCEYom0uUS7rSOkGJWGoTx9rEUps41Fbs5h_7eOA-7-Xes760MMnbEJ0WWe5ciCZKr2wS7P8r_gIk2LMJ |
| CitedBy_id | crossref_primary_10_1080_14992027_2024_2337075 crossref_primary_10_1080_14670100_2024_2415193 crossref_primary_10_1007_s00405_022_07324_8 crossref_primary_10_3389_fnins_2022_976767 crossref_primary_10_1007_s00405_020_06372_2 crossref_primary_10_1080_14670100_2023_2233203 crossref_primary_10_1155_2021_1679907 crossref_primary_10_1371_journal_pone_0307044 crossref_primary_10_1007_s00106_023_01341_7 crossref_primary_10_1007_s00106_023_01342_6 crossref_primary_10_1002_ohn_657 crossref_primary_10_1177_01455613241272467 |
| Cites_doi | 10.1055/s-0034-1390301 10.3109/14992027.2014.895431 10.1044/jshd.2701.62 10.1007/s00405-013-2381-8 10.1177/2331216516673639 10.3766/jaaa.25.2.10 10.3766/jaaa.15012 10.1179/cim.2007.8.1.29 10.1179/1754762814Y.0000000097 10.1016/j.otohns.2008.02.012 10.3109/14992027.2010.509113 10.1097/AUD.0b013e3182251a0e 10.1016/j.ijporl.2016.02.004 10.1097/MAO.0000000000000903 10.1097/AUD.0b013e31828576fb 10.1097/AUD.0b013e31824b9e21 10.1097/MAO.0000000000000781 |
| ContentType | Journal Article |
| Copyright | 2019 Cochlear Europe 2019 |
| Copyright_xml | – notice: 2019 Cochlear Europe 2019 |
| DBID | AAYXX CITATION NPM 7X8 |
| DOI | 10.1080/14670100.2019.1572984 |
| DatabaseName | CrossRef PubMed MEDLINE - Academic |
| DatabaseTitle | CrossRef PubMed MEDLINE - Academic |
| DatabaseTitleList | PubMed MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1754-7628 |
| EndPage | 126 |
| ExternalDocumentID | 30714500 10_1080_14670100_2019_1572984 1572984 |
| Genre | Article Journal Article |
| GroupedDBID | --- 002 0R~ 1OC 1~B 36B 4.4 53G 5GY 6PF AAGDL AALUX AAMIU AAPUL AAQRR AAWTL ABBKH ABDBF ABEIZ ABIJN ABIVO ABLIJ ABUPF ABWVI ABXYU ACENM ACIEZ ACUHS ADCVX AECIN AFRVT AGDLA AGFJD AGRBW AGYJP AIJEM AIRBT AKBVH ALMA_UNASSIGNED_HOLDINGS ALQZU ALYBC AMDAE ARJSQ BLEHA BOHLJ CCCUG CS3 E01 EBD EBS EJD EMB EMOBN ESX F5P H13 HCLVR HZ~ IPNFZ KYCEM LAW LJTGL M4Z OIG P2P P76 P7A P7B QRW RIG RNANH RVRKI RYL SV3 TASJS TBQAZ TERGH TFL TFW TUROJ TUS UEQFS XV2 AAYXX CITATION 0BK 29F 31~ 8-1 ACKZS ACXQS ADFOM ADFZZ ADYSH AEIIZ AFBPY AJAOE CZDIS DRXRE DWTOO M46 NPM 7X8 |
| ID | FETCH-LOGICAL-c366t-a4de3ff4f1564c1b569d6fdb8dd6194baaa331058ecd6a324818b9cdb8ad353c3 |
| ISSN | 1467-0100 1754-7628 |
| IngestDate | Fri Sep 05 13:30:52 EDT 2025 Wed Feb 19 02:31:57 EST 2025 Wed Oct 01 04:26:24 EDT 2025 Thu Apr 24 23:03:51 EDT 2025 Mon Oct 20 23:48:47 EDT 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 3 |
| Keywords | Cochlear implant Nucleus 7 Sound Processor Client oriented scale of improvement Upgrade study |
| Language | English |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-LOGICAL-c366t-a4de3ff4f1564c1b569d6fdb8dd6194baaa331058ecd6a324818b9cdb8ad353c3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 ObjectType-Undefined-3 |
| PMID | 30714500 |
| PQID | 2179500943 |
| PQPubID | 23479 |
| PageCount | 11 |
| ParticipantIDs | informaworld_taylorfrancis_310_1080_14670100_2019_1572984 proquest_miscellaneous_2179500943 pubmed_primary_30714500 crossref_citationtrail_10_1080_14670100_2019_1572984 crossref_primary_10_1080_14670100_2019_1572984 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2019-05-04 |
| PublicationDateYYYYMMDD | 2019-05-04 |
| PublicationDate_xml | – month: 05 year: 2019 text: 2019-05-04 day: 04 |
| PublicationDecade | 2010 |
| PublicationPlace | England |
| PublicationPlace_xml | – name: England |
| PublicationTitle | Cochlear implants international |
| PublicationTitleAlternate | Cochlear Implants Int |
| PublicationYear | 2019 |
| Publisher | Taylor & Francis |
| Publisher_xml | – name: Taylor & Francis |
| References | CIT0010 CIT0020 CIT0001 CIT0012 CIT0011 Dillon H. (CIT0006) 1997; 8 Cox R.M. (CIT0002) 1991; 2 Revit L.J. (CIT0016) 2007 CIT0003 CIT0014 CIT0013 CIT0005 CIT0004 CIT0015 CIT0007 CIT0018 CIT0017 CIT0009 CIT0008 CIT0019 |
| References_xml | – ident: CIT0017 doi: 10.1055/s-0034-1390301 – ident: CIT0010 doi: 10.3109/14992027.2014.895431 – ident: CIT0014 doi: 10.1044/jshd.2701.62 – ident: CIT0011 doi: 10.1007/s00405-013-2381-8 – volume: 2 start-page: 134 year: 1991 ident: CIT0002 publication-title: The Journal of the American Academy of Audiology – volume: 8 start-page: 27 issue: 1 year: 1997 ident: CIT0006 publication-title: The Journal of the American Academy of Audiology – ident: CIT0008 doi: 10.1177/2331216516673639 – ident: CIT0013 doi: 10.3766/jaaa.25.2.10 – ident: CIT0012 doi: 10.3766/jaaa.15012 – ident: CIT0018 doi: 10.1179/cim.2007.8.1.29 – ident: CIT0005 doi: 10.1179/1754762814Y.0000000097 – year: 2007 ident: CIT0016 publication-title: The Hearing Review – ident: CIT0001 doi: 10.1016/j.otohns.2008.02.012 – ident: CIT0007 doi: 10.3109/14992027.2010.509113 – ident: CIT0003 doi: 10.1097/AUD.0b013e3182251a0e – ident: CIT0015 doi: 10.1016/j.ijporl.2016.02.004 – ident: CIT0020 doi: 10.1097/MAO.0000000000000903 – ident: CIT0004 doi: 10.1097/AUD.0b013e31828576fb – ident: CIT0009 doi: 10.1097/AUD.0b013e31824b9e21 – ident: CIT0019 doi: 10.1097/MAO.0000000000000781 |
| SSID | ssj0031454 |
| Score | 2.2189467 |
| Snippet | Objectives: To assess subjective benefits and objective speech recognition performance following a take-home trial with the new Cochlear™ Nucleus
®
7 Sound... To assess subjective benefits and objective speech recognition performance following a take-home trial with the new Cochlear™ Nucleus 7 Sound Processor (SP),... To assess subjective benefits and objective speech recognition performance following a take-home trial with the new Cochlear™ Nucleus® 7 Sound Processor (SP),... |
| SourceID | proquest pubmed crossref informaworld |
| SourceType | Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 116 |
| SubjectTerms | Client oriented scale of improvement Cochlear implant Nucleus 7 Sound Processor Upgrade study |
| Title | Controlled comparative clinical trial of hearing benefit outcomes for users of the Cochlear™ Nucleus® 7 Sound Processor with mobile connectivity |
| URI | https://www.tandfonline.com/doi/abs/10.1080/14670100.2019.1572984 https://www.ncbi.nlm.nih.gov/pubmed/30714500 https://www.proquest.com/docview/2179500943 |
| Volume | 20 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVEBS databaseName: Academic Search Ultimate customDbUrl: https://search.ebscohost.com/login.aspx?authtype=ip,shib&custid=s3936755&profile=ehost&defaultdb=asn eissn: 1754-7628 dateEnd: 20241102 omitProxy: true ssIdentifier: ssj0031454 issn: 1467-0100 databaseCode: ABDBF dateStart: 20040301 isFulltext: true titleUrlDefault: https://search.ebscohost.com/direct.asp?db=asn providerName: EBSCOhost |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3NjtMwELZKV0JcEP-UPxmJcqmypLHz02O3tFqh3XKglXqLYscWlUqytOkBzrwBZy48AA_Bo_AkjP_SVBTtwiWK3Di1Ol_HM-NvZhB6ETGZZ0kQezQRAhwUEXgsY1TdMU4kjYVUycnn0-h0Tt8swkWr9a3BWtpW7Jh_PphX8j9ShTGQq8qS_QfJ1i-FAbgH-cIVJAzXK8l4ZHjmK5FbLrmp4l1nO5qWHMYc1Dw7BppNLqteua1ggtC1GHoqTrFxXIFRyd-rThKaBEG7w6A3VRWPt5vuKOgOx7249041YnIJBjBdR3I_lAzUi-KwF1qDLqu942L3VpWUudLMm2UzErmL6q_XoqhrHuzYyFPDJRiDPqrjB-Wn3FEb7dmWDV6ofKnQM-2Grb6NQ-qBPjYqWBwYs0o68BtgJA2N2zepmn_sBIY6qfYB8Dh9xeEbHPdDcCVMR7r9ytvTt-lkfnaWzsaL2cuLj55qSqYO722HlmvoKIAF-W10NDx5fTJxWz3pU91mr16xSxFL_FcHv3nP-Nkrjft3B0cbOrNb6Kb1UPDQwO02aoniDrp-bjkYd9HXHepwA3XYoQ5r1OFSYos6bFGHHeowLAhr1KmnAHXY4ePXl-_Y4u3nDxxjjTVcYw0rrGGDNdzE2j00n4xno1PPtvbwOImiystoLoiUVKpaRbzPwmiQRzJnSZ6rsBrLsoyA4xEmgudRBkY_2JVswOGBLCch4eQ-ahdlIR4i7EtCk5DGPBAZpeAg01BGfs79gHMJtlYHUfebp9zWvVftV1Zp35bHdaJKlahSK6oOOq6nXZjCL5dNGDQFmlY64iZNe5yUXDL3uZN-CupdndllhSi3mzSADTPU9N8OemBgUS-HqORD-PDRFWY_Rjd2_78nqF2tt-IpmNMVe2ZB_Rv20cxd |
| linkProvider | EBSCOhost |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Controlled+comparative+clinical+trial+of+hearing+benefit+outcomes+for+users+of+the+Cochlear%E2%84%A2+Nucleus%C2%AE+7+Sound+Processor+with+mobile+connectivity&rft.jtitle=Cochlear+implants+international&rft.au=Warren%2C+Chris+D&rft.au=Nel%2C+Esti&rft.au=Boyd%2C+Paul+J&rft.date=2019-05-04&rft.issn=1754-7628&rft.eissn=1754-7628&rft.volume=20&rft.issue=3&rft.spage=116&rft_id=info:doi/10.1080%2F14670100.2019.1572984&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1467-0100&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1467-0100&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1467-0100&client=summon |